
Making a Fertility Plan: Working with Your Endometriosis Care Team
How to turn uncertainty into next steps—testing, treatment choices, and better conversations

Getting told “endometriosis may affect fertility” can land like a life sentence—especially if you’re not even trying yet, or if you’re trying and nothing is happening. Many patients describe living in a stressful in‑between: you may strongly want a child, but feel less able to make a plan because symptoms, surgeries, timing, finances, and fear of delays all collide.
That “stuck” feeling is not just in your head. Population-level research on reproductive health diagnoses (including endometriosis among other conditions) suggests people with these diagnoses are often more likely to desire a child but less likely to intend to have one—pointing to real-world barriers and uncertainty that can disrupt planning even before infertility is formally diagnosed.
This article pulls together findings from several recent papers to help you build a practical, patient-centered fertility plan with your endometriosis (and adenomyosis) care team—so you can move from vague worry to clear, revisit-able decisions.
1) Start with the plan—not the perfect prediction
A common trap is waiting for certainty: “Tell me exactly what my fertility is.” But multiple clinical sources emphasize that before someone actually tries to conceive, precise fertility prediction is usually a rough approximation. What you can do is create a plan that updates as new information arrives.
A useful starting point is to separate desire, intention, and timeline:
- Desire: Do I want children? How strongly? One child or more than one?
- Intention: Am I planning to try? If not, what’s stopping me (pain control, finances, relationship status, fear, career, surgery plans)?
- Timeline: If I do want children, what timing would still feel acceptable to me?
Why this matters: age consistently shows up as a major driver of fertility prognosis in endometriosis counseling. That doesn’t mean you must rush. It means your plan should be realistic about how time interacts with ovarian reserve, treatment choices, and the potential need for assisted reproduction.
2) Build the right care team (and know what each person does)
Endometriosis-related fertility planning works best when it’s shared across disciplines. Many patients benefit from a team approach that can include:
- Endometriosis/gynecology specialist (symptoms, imaging, medical therapy, surgery decisions)
- Reproductive endocrinologist (fertility specialist) (ovulation, ovarian reserve, IUI/IVF strategy)
- Radiology or expert sonographer (high-quality pelvic ultrasound; sometimes MRI)
- Pelvic pain and pelvic floor PT team (pain function, intercourse pain, quality of life)
- Mental health support (decision fatigue, grief, trauma from medical experiences)
This matters because endometriosis management is rarely one obvious “best” choice. A recent protocol paper on digital patient decision aids highlights that endometriosis decisions are often preference-sensitive: several options may be reasonable, and the “right” choice depends on what trade-offs you are willing (or not willing) to make.
3) Get the basics checked early—especially if you’re trying now
If you’re actively trying to conceive and it’s not happening, one consistent theme in clinical guidance is: evaluate both partners early. That includes a semen analysis rather than assuming endometriosis is the only factor.
On your side, first-line evaluation typically includes pelvic ultrasound, and then additional steps based on symptoms and history. Importantly, laparoscopy is not necessarily required “in all cases” just to start fertility evaluation—especially if noninvasive information can guide next steps.
A note about adenomyosis imaging
Adenomyosis can be especially tricky. Guidance emphasizes that ultrasound findings can vary by cycle timing and by which features are present, and agreement between observers for many ultrasound signs can be poor. Practically, that means: if one scan is “unclear” or opinions differ, you haven’t failed—this is a known challenge. Your plan should be guided by a combination of symptoms, imaging quality, and reproductive goals rather than a single ambiguous report.
4) Know your ovarian reserve—then interpret it correctly
For fertility planning, ovarian reserve testing is often a cornerstone, particularly when an endometrioma is present or ovarian surgery is being considered. The most commonly used tests are:
- AMH (anti-müllerian hormone; blood test)
- AFC (antral follicle count; ultrasound count of small follicles)
These results don’t tell you “can you get pregnant or not,” but they help with planning—especially around timing, IVF expectations, and whether fertility preservation should be discussed.
One practical nuance from clinical guidance: AMH and AFC can read lower during hormonal therapy (AMH often reported up to ~20% lower). If you’re on suppression (like combined hormonal contraceptives), ask your clinician how they interpret results in that context and whether repeating testing off hormones would change decisions.
5) Endometrioma decisions: pain relief, recurrence risk, and fertility are not the same goal
If you have an ovarian endometrioma, you’ll likely face a high-stakes decision: treat it medically, leave it alone, drain/sclerose it, or surgically excise it. Evidence across papers reinforces that the best choice depends on what you are optimizing for.
Surgery can reduce recurrence—but may cost ovarian reserve
Clinical guidance consistently warns that endometriomas—and especially their surgical removal—can harm ovarian reserve. This doesn’t mean surgery is “bad.” It means the plan should be individualized: symptom severity, cyst size, prior surgeries, baseline AMH/AFC, and whether IVF is planned all matter.
Some guidance suggests that excision of endometriomas before IVF may not improve IVF success rates, while complete excision can be better for lowering recurrence risk. That’s a crucial distinction: surgery may help certain goals (like recurrence risk, sometimes pain, sometimes access to follicles) without necessarily increasing live birth chances in ART.
Take Control of Your Fertility Journey
Our specialists are here to help you understand your condition and explore your treatment options.
Schedule Your Appointment“Technique details” matter—but don’t expect miracles
A newer surgical study comparing classic stripping to stripping using volumetric hydrodissection (saline to help separate tissue planes) found more intact cyst removal and different specimen-handling patterns, but no clear improvement in AMH drop shortly after surgery and no difference in long-term reproductive outcomes among those reached at 7 years (spontaneous conception and term deliveries were similar).
How to use this in your plan: if you pursue surgery, it’s reasonable to discuss surgeon experience and tissue-sparing techniques. But it’s equally important to go in with realistic expectations: one technique tweak is unlikely to override larger factors like baseline ovarian reserve, disease burden, age, and other infertility factors.
Sclerotherapy + IVF: a pathway with emerging counseling tools
For some patients, ethanol sclerotherapy (ultrasound-guided drainage with alcohol) is considered as an alternative to excision—often with the goal of avoiding ovarian tissue loss and moving faster to IVF.
In a retrospective cohort of patients who had ethanol sclerotherapy and then IVF/ICSI, about half achieved a cumulative live birth when counting all embryo transfers from the first retrieval cycle. Researchers also developed a practical nomogram to estimate individualized live birth probability based on a small set of factors (previous live birth, stimulation protocol, number of eggs retrieved, and cyst diameter).
This doesn’t prove sclerotherapy is “better” than surgery (the study wasn’t designed to compare those approaches head-to-head). But it does support a planning principle: if you are choosing a specific pathway (like sclerotherapy → IVF soon), structured prediction tools may help set expectations and guide discussion—especially about what matters most (time, number of eggs, cyst size, prior reproductive history).
6) If ART or older age is in the picture, plan for pregnancy as “higher risk”
Many endometriosis patients end up considering IVF because of time, tubal factors, ovarian reserve concerns, or repeated disappointments. If that’s you, fertility planning shouldn’t stop at “get pregnant.” It should also include a pregnancy-care plan.
A recent review of advanced maternal age (especially ≥40) and assisted reproductive technologies (ART) highlights that both are linked to higher obstetric risks (miscarriage, hypertensive disorders like preeclampsia, gestational diabetes, placental issues, preterm birth, cesarean delivery, and NICU admission). ART itself is associated with some increased risks even in singleton pregnancies, and risks can be additive when ART and older age overlap.
What this means for your fertility plan:
- Ask not only “what gets me pregnant fastest,” but also “what monitoring will I need once I am pregnant?”
- If donor eggs are part of the discussion, understand the trade-off described in the literature: lower miscarriage risk from embryo aneuploidy, but higher observed risk of preeclampsia in donor-oocyte pregnancies.
7) Use shared decision-making tools to reduce regret and decision fatigue
Because there are multiple reasonable routes (try naturally longer vs earlier IVF, surgery vs no surgery, suppression vs cycling, fertility preservation vs not), many patients benefit from formal shared decision-making.
Research on patient decision aids in endometriosis emphasizes what a true decision aid should do: clearly state the decision, present options with benefits/harms, and help you clarify values. Even before high-quality digital tools are widely available, you can borrow the same structure:
- What decision am I actually making right now?
- What are my realistic options?
- What do I gain and what do I give up with each?
- What matters most to me this year (pain relief, time, minimizing procedures, maximizing chance of ≥2 children, avoiding recurrence, etc.)?
This approach can also soften the “desire–intention mismatch” seen in broader population research: you’re not forcing yourself to choose a single permanent answer—you’re building a stepwise plan that matches your priorities and constraints.
Practical takeaways: bring these questions to your next appointment
Use these prompts to turn your visit into a planning session:
- “Based on my age and ovarian reserve (AMH/AFC), what is a realistic timeline for trying naturally vs moving to ART?”
- “Do you recommend checking my ovarian reserve now, and if I’m on hormonal therapy, how will that affect interpretation?”
- “If I have an endometrioma, what is the goal of treating it—pain, recurrence risk, access for egg retrieval, cancer concern, fertility—and which option best matches that goal?”
- “If surgery is on the table, what steps do you take to minimize ovarian damage, and how might surgery affect my AMH/AFC?”
- “Should we discuss fertility preservation (egg/embryo freezing) before any ovarian surgery or before delaying pregnancy?”
- “What other factors are we checking besides endometriosis—especially semen analysis and tubal/uterine factors?”
- “If I conceive via IVF or at an older age, what pregnancy monitoring plan do you recommend from the start?”
What we still don’t know (and why your plan must stay flexible)
Even with better imaging, better IVF, and more specialized surgery, there are real evidence gaps:
- Adenomyosis diagnosis and severity remain difficult to standardize; ultrasound interpretation can vary and some features are cycle-dependent. That uncertainty affects counseling and research comparisons.
- Many comparisons of surgical techniques (or surgery vs alternatives like sclerotherapy) are limited by study design, incomplete follow-up, and differences in patient selection—so results don’t always translate cleanly to an individual.
- Prediction tools (like nomograms for live birth after specific treatment pathways) can help counseling but don’t replace individualized medical judgment, and may not apply outside the exact scenario studied.
- Fertility planning is not purely biological. Broader research suggests diagnoses can shape confidence, perceived barriers, and intention, but studies often can’t tell us which experiences (pain severity, medical trauma, cost, relationship status, work constraints) drive that gap—yet these factors strongly influence real decisions.
A good fertility plan for endometriosis isn’t a one-time “answer.” It’s a living document you update as your symptoms change, your life changes, and new test results come in—built with a care team that understands both the medical evidence and the emotional weight of uncertainty.
References
Beyer, Drazic, Bitto et al.. Endometriosis and Fertility: A Practical Guide. Geburtshilfe und Frauenheilkunde. 2025. PMID: 41684534 PMCID: PMC12893803
. Reproductive Outcome After Laparoscopic Ovarian Endometrioma Stripping With Volumetric Hydrodissection. Obstetrics and Gynecology International. 2026. PMID: 41717279 PMCID: PMC12914591
Liu, Li, Zhou et al.. Development and validation of a clinical nomogram for predicting cumulative live birth rate in ovarian endometrioma patients undergoing ethanol sclerotherapy and in vitro fertilization/intracytoplasmic sperm injection. Frontiers in Endocrinology. 2026. PMID: 41727695 PMCID: PMC12920196
Pittet, Delvallée, Pluchino et al.. Digital patient decision aids for endometriosis management: a scoping review protocol. BMJ Open. 2026. PMID: 41734921 PMCID: PMC12933810
Guzzo, Broussard. Women’s Reproductive Health Conditions and Fertility Goals. Population Research and Policy Review. 2026. PMID: 41769245 PMCID: PMC12935700
Méndez-Vidal, Fernández-Sánchez, Domínguez-Moreno et al.. Advanced maternal age and assisted reproductive technologies: outcomes, genomics, and real-world evidence. Frontiers in Reproductive Health. 2026. PMCID: PMC12979401
Quick Answers
How rare is endosalpingiosis?
Endosalpingiosis is generally considered uncommon, but “how rare” it is depends heavily on who’s being studied and how it’s found. Many cases are discovered incidentally on pathology—meaning tissue is identified under the microscope after surgery done for other reasons—so it’s likely underrecognized in the general population. In other settings (like surgical cohorts), it may appear more often simply because more tissue is being sampled and examined carefully.
What matters most for patients is that endosalpingiosis can be confused with endometriosis on imaging or even at surgery, yet it doesn’t always behave the same way clinically. If you’ve been told you have endosalpingiosis and you also have pelvic pain, bowel/bladder symptoms, or fertility concerns, our team can help interpret what that finding means in the context of your symptoms and operative/pathology reports. You’re welcome to explore our educational content on related endometriosis and uterine conditions, and reach out to schedule a consultation if you want a personalized plan.
How does estrogen affect the endometrium?
Estrogen is one of the main hormones that drives endometrial growth. In the first half of the menstrual cycle, rising estrogen signals the endometrium to thicken and rebuild after a period, preparing the uterus for a possible pregnancy. It also influences the local immune and inflammatory environment in the uterus, which is part of why hormonal shifts can change bleeding patterns and pain.
When estrogen’s growth signals are strong—and progesterone’s “calming” effect is weaker than expected (often described as progesterone resistance)—the endometrium can behave in a more persistently inflamed, reactive way. This hormone–inflammation pattern is especially relevant in estrogen-dependent conditions like adenomyosis and endometriosis, where tissue similar to the endometrium can contribute to ongoing symptoms. If you’re trying to make sense of heavy bleeding, severe cramping, or cycle-linked pelvic pain, our team can help you connect the hormonal biology to what you’re feeling and review next steps for diagnosis and treatment.
What does advanced adenomyosis mean?
“Advanced adenomyosis” usually means the adenomyosis is more extensive within the uterine muscle—often involving a larger area (diffuse disease), deeper penetration into the myometrium, and/or more pronounced changes like uterine enlargement and tenderness. It’s not the same as “advanced endometriosis,” because adenomyosis doesn’t spread outside the uterus; “advanced” is more about how much of the uterine wall appears affected and how significantly it’s impacting symptoms.
Because adenomyosis doesn’t have a single universally accepted staging system, different clinicians and radiology reports may use “advanced” to summarize imaging features (ultrasound or MRI) and the overall clinical picture—such as heavy bleeding, severe period pain, pelvic pressure, or fertility challenges. In our practice, we focus less on the label and more on what your imaging suggests (diffuse vs focal/adenomyoma, junctional zone changes, uterine size) and what your goals are (pain control, bleeding control, fertility preservation, or definitive treatment). If you’ve been told you have “advanced adenomyosis,” our team can help you interpret what that means in your specific case and map out next steps.
What does a frozen pelvis mean with endometriosis?
A “frozen pelvis” isn’t a separate diagnosis—it’s a descriptive term surgeons use when the uterus is essentially stuck in place because endometriosis-related inflammation has caused dense scarring (adhesions). Instead of the uterus moving freely, it may be tethered to nearby structures like the bowel, bladder, ovaries, or pelvic sidewall, sometimes pulling the uterus into an abnormal position and making pelvic anatomy hard to distinguish. Thus some have also called it a "frozen uterus".
This finding often suggests more advanced disease, such as deep infiltrating endometriosis and/or significant adhesions from prior inflammation or surgery, and it can help explain symptoms like deep pelvic pain, painful sex, bowel or bladder symptoms, or pain that doesn’t match what a routine exam shows. In these cases, surgery is less about “burning spots” and more about carefully restoring normal anatomy—freeing organs, protecting ureters and bowel, and removing endometriosis at its roots. If you’ve been told your uterus is “frozen,” our team can help you understand what that implies for imaging, surgical planning, and which adjacent organs may need to be evaluated as part of a complete excision strategy.
What are peritoneal pockets in endometriosis?
Peritoneal pockets are small “indentations” or fold-like defects in the peritoneum—the thin lining that covers the pelvic organs and inner abdominal wall. In endometriosis surgery, we may see these pockets as tucked-in areas or little pits in the peritoneal surface, and they can be associated with superficial peritoneal endometriosis or early/developing disease patterns.
These pockets matter because endometriosis doesn’t always look like obvious black or red implants; it can hide within subtle anatomic changes, scarring, or altered peritoneal contours. In the operating room, careful inspection and technique are important so that disease within or around a peritoneal pocket isn’t missed or only treated on the surface. If you’ve been told you have “peritoneal pockets,” our team can help you understand what that finding may mean in your case—based on your symptoms, imaging, and whether deeper structures (like bowel, bladder, or ureters) could also be involved.


